American and European Regulations

Giorgio Pajardi; C. Parolo; S. Willbrand; L. Hurst; L. B. Grablutz

doi:10.1007/978-3-319-65822-3_9

American and European Regulations

Giorgio Pajardi
, C. Parolo
, S. Willbrand
, L. Hurst
, L. B. Grablutz

Orthopaedics

University of Milan
Ospedale San Giuseppe, Milano
Uppsala University
American Drugs Regulation Consultant

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

In the last two decades, the topic on how to manage the access of new health technologies (including drugs, vaccines, medical devices, medical procedures, etc.) is on top of the agenda of the decision makers in health care in most of the developed countries.

Original language	English
Title of host publication	Collagenase in Dupuytren Disease
Publisher	Springer International Publishing
Pages	119-130
Number of pages	12
ISBN (Electronic)	9783319658223
ISBN (Print)	9783319658216
DOIs	https://doi.org/10.1007/978-3-319-65822-3_9
State	Published - Jan 1 2018

Access to Document

10.1007/978-3-319-65822-3_9

Cite this

@inbook{55f3a1f6a1934671bc74759e209ff8b5,

title = "American and European Regulations",

abstract = "In the last two decades, the topic on how to manage the access of new health technologies (including drugs, vaccines, medical devices, medical procedures, etc.) is on top of the agenda of the decision makers in health care in most of the developed countries.",

author = "Giorgio Pajardi and C. Parolo and S. Willbrand and L. Hurst and Grablutz, \{L. B.\}",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing AG, part of Springer Nature 2018.",

year = "2018",

month = jan,

day = "1",

doi = "10.1007/978-3-319-65822-3\_9",

language = "English",

isbn = "9783319658216",

pages = "119--130",

booktitle = "Collagenase in Dupuytren Disease",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - American and European Regulations

AU - Pajardi, Giorgio

AU - Parolo, C.

AU - Willbrand, S.

AU - Hurst, L.

AU - Grablutz, L. B.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - In the last two decades, the topic on how to manage the access of new health technologies (including drugs, vaccines, medical devices, medical procedures, etc.) is on top of the agenda of the decision makers in health care in most of the developed countries.

AB - In the last two decades, the topic on how to manage the access of new health technologies (including drugs, vaccines, medical devices, medical procedures, etc.) is on top of the agenda of the decision makers in health care in most of the developed countries.

UR - https://www.scopus.com/pages/publications/105011911032

U2 - 10.1007/978-3-319-65822-3_9

DO - 10.1007/978-3-319-65822-3_9

M3 - Chapter

AN - SCOPUS:105011911032

SN - 9783319658216

SP - 119

EP - 130

BT - Collagenase in Dupuytren Disease

PB - Springer International Publishing

ER -

American and European Regulations

Abstract

Access to Document

Other files and links

Fingerprint

Cite this